Lacosamide Medical Valley Filmuhúðuð tafla 100 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

lacosamide medical valley filmuhúðuð tafla 100 mg

medical valley invest ab - lacosamidum inn - filmuhúðuð tafla - 100 mg

Lacosamide Medical Valley Filmuhúðuð tafla 150 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

lacosamide medical valley filmuhúðuð tafla 150 mg

medical valley invest ab - lacosamidum inn - filmuhúðuð tafla - 150 mg

Lacosamide Medical Valley Filmuhúðuð tafla 200 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

lacosamide medical valley filmuhúðuð tafla 200 mg

medical valley invest ab - lacosamidum inn - filmuhúðuð tafla - 200 mg

Lacosamide Medical Valley Filmuhúðuð tafla 50 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

lacosamide medical valley filmuhúðuð tafla 50 mg

medical valley invest ab - lacosamidum inn - filmuhúðuð tafla - 50 mg

Lacosamide Accord Evrópusambandið - íslenska - EMA (European Medicines Agency)

lacosamide accord

accord healthcare s.l.u. - lacosamíð - flogaveiki - antiepileptics, - lacosamide accord is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy. lacosamide accord is indicated as adjunctive therapy•         in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy. •         in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.

Lacosamide UCB Evrópusambandið - íslenska - EMA (European Medicines Agency)

lacosamide ucb

ucb pharma s.a. - lacosamíð - flogaveiki, partial - antiepileptics, - lacosamide ucb er ætlað eitt og sér og venjulega meðferð í meðferð á hluta-upphaf flog með eða án efri almenn ákvörðun er tekin í fullorðnir, unglingum og börn, frá 4 ára aldri með flogaveiki.

Lacosamide Adroiq Evrópusambandið - íslenska - EMA (European Medicines Agency)

lacosamide adroiq

extrovis eu ltd. - lacosamíð - flogaveiki - antiepileptics, - lacosamide adroiq is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. lacosamide adroiq is indicated as adjunctive therapyin the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.

Pramipexole Accord Evrópusambandið - íslenska - EMA (European Medicines Agency)

pramipexole accord

accord healthcare s.l.u. - pramipexól tvíhýdróklóríð einhýdrat - parkinson disease; restless legs syndrome - anti-parkinsonslyf - pramipexole accord er ætlað fullorðnum til meðferðar á einkennum parkinsonsveiki, einkennalaus (án levodopa) eða í samsettri meðferð með levodopa, ég. á meðan á sjúkdómnum stendur, í gegnum seint stig þegar áhrif levódópa berast eða verða ósamræmi og sveiflur á meðferðaráhrifum eiga sér stað (lokaskammtur eða "á-burt" sveiflur).

Darunavir Medical Valley Filmuhúðuð tafla 600 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

darunavir medical valley filmuhúðuð tafla 600 mg

medical valley invest ab - darunavir propylene glycolate - filmuhúðuð tafla - 600 mg

Darunavir Medical Valley Filmuhúðuð tafla 800 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

darunavir medical valley filmuhúðuð tafla 800 mg

medical valley invest ab - darunavir propylene glycolate - filmuhúðuð tafla - 800 mg